Harm Reduction Strategies for People Who Use Drugs
This JAMA Insights explores harm reduction strategies for people who use drugs and the clinicians who treat them to help reduce the risk of unintentional drug overdose and infection.
Related Articles
Oral Muvalaplin for Lowering of Lipoprotein(a)
This randomized clinical trial assesses the effect of muvalaplin on lipoprotein(a) concentrations in patients with high baseline lipoprotein(a) levels and cardiovascular risk factors.
American Heart Association Scientific Session Articles
Explore special articles published online first to coincide with presentations at AHA American Heart Association’s Annual Scientific Session.
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
This phase 2 randomized clinical trial evaluates the optimal dose, dosing interval, and safety of zerlasiran, a small-interfering RNA targeting hepatic synthesis of apolipoprotein(a), to…
Semaglutide Eligibility Across All Current Indications for US Adults
This cross-sectional study uses National Health and Nutrition Examination Survey data to examine the number of US adults eligible for semaglutide across all current indications.
Shingles Vaccine Could Protect Cardiovascular Health
Pharmacists can continue to spread awareness of the importance of receiving a shingles vaccine.
Macronutrient concentrations in human milk beyond the first half year of lactation: a cohort study
Objective Human milk composition is dynamic. While extensive research has focused on its macronutrient concentrations during the first 6 months of lactation, limited research exists…
Neurodevelopment at Age 9 Years Among Children Born at 32 to 36 Weeks’ Gestation
This cohort study investigates whether moderate to late preterm birth (32 to 36 weeks’ gestation) is associated with neurodevelopmental outcomes at age 9 years among…
Listeria Susceptibility in Patients With Multiple Myeloma Receiving Daratumumab-Based Therapy
This case-control study examines the association of Listeria monocytogenes susceptibility with the receipt of daratumamab-based therapy in Canadian patients with multiple myeloma.
Resuscitation and Outcomes in Patients With Asystole Out-of-Hospital Cardiac Arrest
This cohort study describes the secular trends in patient outcomes and advanced life support procedures and evaluates the associations between prehospital procedures and outcomes in…
Federally Qualified Health Centers and Performance of Medicare ACOs
This cross-sectional study compared beneficiary characteristics, utilization, expenditure, and quality between accountable care organizations (ACOs) with and without federally qualified health center (FQHC) participation and…